Journal of Peking University(Health Sciences) ›› 2016, Vol. 48 ›› Issue (2): 287-291. doi: 10.3969/j.issn.1671-167X.2016.02.020

• Article • Previous Articles     Next Articles

Feasibility study of dynamic contrast enhanced magnetic resonance imaging qualitative diagnosis of musculoskeletal tumors

ZHANG Jing 1, ZUO Pan-li 2, CHENG Ke-bin1, YU Ai-hong1, CHENG Xiao-guang1△   

  1. (1. Department of Radiology, Beijing Jishuitan Hospital, Beijing 100035, China; 2. Siemens Healthcare, Magnetic Resonance Collaboration Northeast Asia, Beijing 100102, China )
  • Online:2016-04-18 Published:2016-04-18
  • Contact: CHENG Xiao-guang E-mail:xiao65@263.net
  • Supported by:

    Supported by Beijing High Levels of Health Technical Talent Team of Construction Project(2009-02-03, 2013-3-033)

Abstract:

Objective: To investigate the feasibility of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) parameters in differentiating musculoskeletal tumors with different behaviours of pathological findings before therapy. Methods: A total of 34 subjects of musculoskeletal tumors were involved in this retrospective analysis. DCE-MRI was performed using a fat-saturated 3D VIBE (volumetric interpolated breath-hold exam) imaging sequence with following parameters: FA, 10 degree; TR/TE, 5.6/2.4 ms; slice thickness, 4.0 mm with no intersection gap; field of view, 310 mm×213 mm; matrix, 256×178; voxel size, 1.2 mm×1.2 mm×4.0 mm; parallel imaging acceleration factor. The actuation time for the DCE-MRI sequence was 255 s with a temporal resolution of 5 s and 40 image vo-lumes. Using pathological results as a gold standard, tumors were divided into benign, borderline and malignant tumors. Toft’s model was used for calculation of Ktrans (volume transfer constant), Ve (extravascular extracellular space distribute volume per unit tissue volume) and Kep (microvascular permeability reflux constant). Those parameters were compared between the lesions and the control tissues using paired t-tests. The one-way analysis of variance was used to assess the difference among benign, borderline and malignant tumors. P values <0.05 difference was statistically significant. Results: Based on the WHO Classification of Tumours of Soft Tissue and Bone(2012) criteria, 34 patients were divided into three groups: 11 for benign tumors, 12 for borderline tumors, and 11 for malignancies. Compared with control tissues, Ktrans and Kep showed no difference, but Ve was increased in benign tumors, Kep showed no diffe-rence, but Ktrans and Ve were increased in borderline tumors,Ktrans, Kep and Ve were increased in malignant tumors. Ktrans (P<0.001) and Kep (P<0.01) were significantly higher in malignant tumors than in benign and borderline tumors, but did not show any difference between benign tumors and borderline tumors. Ve was significantly higher in malignant tumors than in benign (P<0.05), but did not show any difference between malignant and borderline tumors, benign tumors and borderline tumors (P>0.05). Conclusion: DCE-MRI technique is useful to evaluate the pathological behaviour of musculoske-letal tumors. The quantitative analysis of DCE parameters in conjunction with conventional MR images can improve the accuracy of musculoskeletal tumor qualitative analysis.

Key words: Musculoskeletal system, Neoplasms, Magnetic resonance imaging, Diagnosis

CLC Number: 

  • R814.46
[1] Jiafu JI, Jingtao WEI, Ke JI, Zhaode BU. Bottlenecks and breakthroughs in gastric cancer diagnosis and treatment: Towards a new era of precision and intelligent integration [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 231-238.
[2] Jiale GAO, Zhongtao ZHANG. Current status and future perspectives of precision treatment for locally advanced rectal cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 247-250.
[3] Youdong LIU, Yajun LYU, Jie CHEN, Mingde ZANG, Hongda PAN, Xiaowen LIU, Jun LU, Fenglin LIU. Clinical efficacy and safety of totally laparoscopic subtotal gastrectomy with cardia-gastric fundus preservation in middle-upper gastric cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 301-306.
[4] Jialin LI, Liqiao CHEN, Jiatian TANG, Yan WU, Anqiang WANG. Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 399-404.
[5] Bin LI, Han LIANG. Robotic gastrectomy: Research progress and practical challenges [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 416-422.
[6] Ye ZHAO, Xiaoli DIAO, Yan XIONG. Application of cell transfer technology in pathological diagnosis of micro-volume cell fluid [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 208-213.
[7] Yue WANG, Yuhong LIANG. Florid cemento-osseous dysplasia: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 220-224.
[8] Yanting CHI, Hongjie JIANG, Yan CHEN, Zhixiu XU, Binbin LI. Value of direct immunofluorescence in the diagnosis of oral mucosal pemphigus vulgaris: A retrospective study based on multi-index combined analysis [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 68-73.
[9] Yanhua LIU, Min LU, Xuyang ZHAO, Kuan'gen ZHANG, Rui WU, Fang MEI, Zhihao DAI, Jiangfeng YOU, Fei PEI. Effect of dephosphorylation of tumor metastasis suppressor gene LASS2 on vacuolar ATPase activity and invasiveness of prostate cancer [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1113-1123.
[10] Jingyan GU, Xinyi LI, Jinxia ZHAO, Rong MU. Diabetic Charcot neuroarthropathy initially misdiagnosed as rheumatoid arthritis and gout: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1193-1197.
[11] Xiaodi XIAO, Youchen XIA, Jianying LIU, Peng FU. Left sided sternocleidomastoid interosseous intravascular papillary endothelial hyperplasia: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 1002-1004.
[12] Xiangyu SUN, Chao YUAN, Xinzhu ZHOU, Jing DIAO, Shuguo ZHENG. Application of salivary micro-ecosystem in early prevention and control of oral and systemic diseases [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 859-863.
[13] Xiaoyong YANG, Fan ZHANG, Lulin MA, Cheng LIU. Clinical characteristics and influencing factors of extraglandular invasion of prostatic ductal adenocarcinoma [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 956-960.
[14] Jiaxin NING, Haoran WANG, Shuhang LUO, Jibo JING, Jianye WANG, Huimin HOU, Ming LIU. Multi-omics analysis of the relationship between oxidative stress-related gene and prostate cancer [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 633-643.
[15] Zeyuan WANG, Shuanbao YU, Haoke ZHENG, Jin TAO, Yafeng FAN, Xuepei ZHANG. A preoperative prediction model for pelvic lymph node metastasis in prostate cancer: Integrating clinical characteristics and multiparametric MRI [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 684-691.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!